Lacosamide 68462-0680
Product NDC
68462-0680- Manufacturer
- Glenmark Pharmaceuticals Inc. Usa
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- March 18, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA205006
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 150 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(3)
1000 TABLET, FILM COATED in 1 BOTTLE (68462-680-10)
30 TABLET, FILM COATED in 1 BOTTLE (68462-680-30)
60 TABLET, FILM COATED in 1 BOTTLE (68462-680-60)